`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Filed: November 30, 2017
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`CIPLA LTD.,
`Petitioners,
`
`v.
`ABRAXIS BIOSCIENCE, LLC,
`Patent Owner.
`
`
`
`Case IPR2018-00162
`Patent 7,820,788
`
`PATENT OWNER’S MANDATORY NOTICES
`
`
`
`
`
`
`Case IPR2018-00162
`Patent 7,820,788
`Patent Owner Mandatory Notices
`
`Abraxis BioScience, LLC, the Patent Owner, provides the following
`
`mandatory notices pursuant to 37 C.F.R. § 42.8.
`
`I.
`
`REAL PARTY-IN-INTEREST
`In accordance with 37 C.F.R. § 42.8(b)(1), Patent Owner identifies Abraxis
`
`Biosciences, LLC (“Abraxis”) and Celgene Corporation (“Celgene”) as real
`
`parties-in-interest. Celgene is a corporation organized and existing under the laws
`
`of the State of Delaware, having a principal place of business at 86 Morris Avenue,
`
`Summit, New Jersey 07901. Abraxis is a wholly owned subsidiary of Celgene.
`
`Abraxis, a corporation organized and existing under the laws of the State of
`
`Delaware, having a principal place of business at 11755 Wilshire Boulevard, 20th
`
`Floor, Los Angeles, California 90025, is the owner of all right, title and interest in
`
`U.S. Patent No. 7,820,788 (“the ’788 Patent”) by virtue of an assignment from the
`
`inventors, Neil P. Desai, Patrick Soon-Shiong, and Vuong Trieu. The Assignment
`
`was recorded on October 16, 2008 at Reel 021694, Frame 0568.
`
`II. RELATED MATTERS
`Pursuant to 37 C.F.R. § 42.8(b)(2), Patent Owner identifies the following:
`
`
`
`A.
`
`Proceedings Before the USPTO Involving Related Patents
`• The ’788 Patent is the subject of IPR2017-01101 and IPR2018-00152.
`
`• U.S. Patent No. 7,923,536 (“the ’536 Patent”), which issued from U.S.
`
`Application Serial No. 12/758,413, is a continuation of U.S.
`
`
`
`
`
`
`
`Application Serial No. 11/553,339, which issued as the ’788 Patent.
`
`The ’536 Patent is the subject of IPR2017-01103, IPR2018-00153,
`
`and IPR2018-00163.
`
`• U.S. Patent No. 8,138,229 (“the ’229 Patent”), which issued from U.S.
`
`Application Serial No. 12/910,693, is a continuation of U.S.
`
`Application Serial No. 11/553,339, which issued as the ’788 Patent.
`
`The ’229 Patent is the subject of IPR2017-01104, IPR2018-00151,
`
`and IPR2018-00164.
`
`Litigations Involving the Patent-at-Issue
`B.
`The ’788 Patent is the subject of the following pending litigations:
`
`• Abraxis Bioscience, LLC et al v. Actavis, LLC, 2:16-cv-09074-JMV-
`
`MF (D.N.J. April 6, 2016).
`
`• Abraxis Bioscience, LLC et al v. Cipla Ltd., 2:16-cv-09074-JMV-MF
`
`(D.N.J. Dec. 7, 2016).
`
`III. LEAD AND BACKUP COUNSEL AND SERVICE INFORMATION
`In accordance with 37 C.F.R. §§ 42.8(b)(3), 42.8(b)(4), and 42.10(a), Patent
`
`Owner identifies the following lead and backup counsel and service information:
`
`Lead counsel:
`
`
`
`
`
`
`
`Christopher J. Harnett (Reg. No. 35,538)
`Jones Day
`250 Vesey Street
`New York, NY 10281-1047
`Tel: (212) 326-3939
`Fax: (212) 755-7306
`Email: charnett@jonesday.com
`-3-
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Backup counsel:
`
`Anthony M. Insogna (Reg. No. 35,203)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel: (858) 314-1200
`Fax: (844) 345-3178
`Email: aminsogna@jonesday.com
`
`Cary Miller, Ph.D. (Reg. No. 54,708)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel: (858) 314-1200
`Fax: (844) 345-3178
`Email: cmiller@jonesday.com
`
`Lisamarie LoGiudice, Ph.D. (Reg. No.
`71,047)
`Jones Day
`250 Vesey Street
`New York, NY 10281-1047
`Tel: (212) 326-3939
`Fax: (212) 755-7306
`Email: llogiudice@jonesday.com
`
`F. Dominic Cerrito (Reg. No. 38,100)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7112
`Fax: (212) 849-7100
`Email: nickcerrito@quinnemanuel.com
`
`Andrew S. Chalson (pro hac vice)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7112
`Fax: (212) 849-7100
`Email:
`andrewchalson@quinnemanuel.com
`
`J. Patrick Elsevier, Ph.D. (Reg. No.
`44,668)
`Celgene Corporation
`Vice President Litigation
`86 Morris Ave
`Summit, NJ 07901
`Tel: (908) 673-9000
`Email: pelsevier@celgene.com
`
`Frank C. Calvosa (Reg. No. 69,064)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7112
`Fax: (212) 849-7100
`Email:
`frankcalvosa@quinnemanuel.com
`
`Daniel C. Wiesner (pro hac vice)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7112
`Fax: (212) 849-7100
`Email:
`danielwiesner@quinnemanuel.com
`
`-4-
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Patent Owner consents to electronic service by email.
`
`
`Respectfully submitted,
`
`Dated: November 30, 2017 /s/Christopher J. Harnett
`
`
`
`Christopher J. Harnett
`
`
`
`
`(Reg. No. 35,538)
`
`
`Jones Day
`
`
`250 Vesey Street
`
`
`New York, NY 10281
`
`
`Tel: (212) 326-3939
`
`
`Fax: (212) 755-7306
`
`
`Email: charnett@jonesday.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`-5-
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Petitioner a true and correct copy of the foregoing “Patent Owner’s
`
`Mandatory Notices” by electronic means on November 30, 2017 at the
`
`following email addresses of record:
`
`Lead Counsel
`Michael J. Freno
`K&L GATES LLP
`925 Fourth Avenue, Suite 2900
`Seattle, WA 98104
`Telephone: 206.370.7947
`Facsimile: 206.623.7022
`Email: michael.freno@klgates.com
`
`
`
`Backup Counsel
`
`Anil Patel
`K&L GATES LLP
`1000 Main Street, Suite 2550
`Houston, TX 77002
`Telephone: 713.815.7304 Facsimile:
`713.583.9417
`Email: anil.patel@klgates.com
`
`Jason A. Engel
`K&L GATES LLP
`70 W. Madison Street, Suite 3100
`Chicago, IL 60602
`Telephone: 312.807.4236
`Facsimile: 312.827.8145
`Email: jason.engel.ptab@klgates.com
`
`Peter L. Giunta (Reg. No. 55,207)
`K&L GATES LLP
`599 Lexington Avenue
`New York, NY 10022
`Telephone: 212.536.3910
`Facsimile: 212.536.3901
`Email: peter.giunta@klgates.com
`
`Elizabeth Weiskopf
`K&L GATES LLP
`925 Fourth Avenue, Suite 2900
`Seattle, WA 98104
`Telephone: 206.370.7964
`Facsimile: 206.623.7022
`Email: elizabeth.weiskopf@klgates.com
`
`
`
`Dated: November 30, 2017
`
`
`
`
`
`/s/ Lisamarie LoGiudice, Ph.D.
`Lisamarie LoGiudice, Ph.D. (Reg. No.
`71,047)
`JONES DAY
`250 Vesey Street
`New York, NY 10281-1047
`Telephone: 212-326-3939
`Facsimile: 212-755-7306
`
`Counsel for Patent Holder
`Abraxis Bioscience, LLC
`
`
`
`
`
`
`
`
`
`